List view / Grid view

Contract Manufacturing

Filter the results

 

article

Trends in the CDMO industry for 2020

20 February 2020 | By

Over the past decade, the pharmaceutical industry has witnessed rapid growth in outsourcing services, driven by various factors including the growth of small molecules, increasing API complexities and the need to optimise costs. Here, Peter DeYoung shares his thoughts on the key trends he expects to see in the contract…

article

Regulatory non-compliance business interruptions

29 October 2019 | By

Loss of manufacturing capability as a result of regulatory non-compliance can have a devastating impact on biopharma or medical device manufacturers. In this article, Jenny Yu shares real-life examples from the industry and highlights the downstream effects of these business interruptions.